Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation. Bone Marrow Tran- splant 2012; 47: 24-32.Milone G, Poidomani M, Leotta S, et al. Prognostic value of CD34þ peak in ...
ORIGINAL ARTICLENegative prognostic value of CD34 antigen also if expressedon a small population of acute promyelocitic leukemia cellsMassimo Breccia & Maria Stefania De Propris & Caterina Stefanizzi &Sara Raponi & Matteo Molica & Gioia Colafigli & Clara Minotti &Rob...
Carter BZ, Qiu Y, Huang X et al (2012) Survivin is highly expressed in CD34+38− leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood 120(1):173–180 Article CAS PubMed PubMed Central Google Scholar Cerrano M, Itzykson R (2019) New treatment options for ...
versus other combinations), ABO incompatibility (major versus minor or none), diagnosis (malignant versus nonmalignant), status of disease (low, medium, or high risk), conditioning regimen (use of a radiation or busulfan-based conditioning), and nucleated cell and CD34+ marrow cell doses (...
Theilgaard-Monch K, Raaschou-Jensen K, Heilmann C, Andersen H, Bock J, Russel CA, Vindelov L, Jacobsen N, Dickmeiss E (1999) A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allo grafts. Eur J ...
Prostate cancer, the second most frequently diagnosed cancer in males worldwide, is estimated to be diagnosed in 1.1 million men per year. Introduction of PSA testing substantially improved early detection of prostate cancer, however it also led to overd
However, this is unlikely considering that the level of WT1 expression in CD34+ normal hematopoietic progenitor cells is as high as in leukemic cells. Second, the expression of MHC class I molecules may be lower in physiologically WT1 expressing normal cells than in WT1 expressing tumor cells. ...
Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients. Br J Haematol 2004; 128: 42–48. Google Scholar Barosi G, Ambrosetti A, Centra A, Rosti V, Piaggio G, Marchetti M et al. Splenectomy and risk of blast ...
Sets 4 and 5 contain genes typical of endothelial tissue, both actual angiogenic regulators TIE1/TIE2 (TEK), ARHGEF15, ROBO4, and ELTD1 and other endothelial markers such as CD34, CLEC14A, and ESAM. Several (7/12) of the genes in gene sets 4 and 5 were identified in the angiogenes...
Sets 4 and 5 contain genes typical of endothelial tissue, both actual angiogenic regulators TIE1/TIE2 (TEK), ARHGEF15, ROBO4, and ELTD1 and other endothelial markers such as CD34, CLEC14A, and ESAM. Several (7/12) of the genes in gene sets 4 and 5 were identified in the angiogenes...